{
  "url": "https://struct.news/briefs/crinetics-grew-revenue-2336-the-loss-barely-moved",
  "title": "Crinetics grew revenue 2,336%. The loss barely moved.",
  "summary": "Revenue reached $25.1 million from $1.0 million, while six-month operating cash use rose to $218.9 million.",
  "published_at": "2026-08-03T20:15:05.002313+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "Crinetics Pharmaceuticals, Inc.",
    "ticker": "CRNX",
    "cik": "1658247",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "source_filing": {
    "form": "10-Q",
    "filed": "2026-08-03",
    "accession": "0001658247-26-000053",
    "url": "https://www.sec.gov/Archives/edgar/data/1658247/000165824726000053/crnx-20260630.htm"
  },
  "comparison_filing": {
    "form": "10-Q",
    "filed": "2025-08-07",
    "url": "https://www.sec.gov/Archives/edgar/data/1658247/000119312525175498/crnx-20250630.htm"
  },
  "reported_figures": [
    {
      "group": "The filing in three numbers",
      "label": "Revenue",
      "value": 7696000,
      "display": "$7.7M",
      "unit": "usd",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "sec_filing",
        "label": "Filed company results",
        "form": "10-Q",
        "accession": "0001658247-26-000053",
        "filing_date": "2026-08-03"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Revenue YoY",
      "value": 640.7122232916266,
      "display": "+640.7%",
      "unit": "percent",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001658247-26-000053",
        "filing_date": "2026-08-03"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Operating margin",
      "value": -6714.773908523908,
      "display": "-6714.8%",
      "unit": "percent",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001658247-26-000053",
        "filing_date": "2026-08-03"
      }
    }
  ],
  "watch_next": [
    {
      "type": "regulation",
      "statement": "The planned Vertex merger remains subject to shareholder approval, HSR waiting-period action, and foreign regulatory clearances, with closing currently expected in the third quarter of 2026.",
      "importance": "high",
      "evidence": "The Merger is currently expected to close in the third quarter of 2026, subject to customary closing conditions, including receipt of the Company Shareholder Approval, expiration or termination of the waiting period under the HSR Act and receipt of any required foreign regulatory clearances.",
      "source_date": "2026-08-03"
    }
  ],
  "related_tickers": [
    "CRNX",
    "VERX"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}